Bioworld Financial Watch articles from October 2004

Bioworld Financial Watch archives from October 2004

Prostate cancer report: cases rising, but progress being made.
October 4, 2004... The Prostate Cancer Foundation recently released a manuscript titled "Report to the Nation on Prostate Cancer 2004," which detailed, in nearly 100 pages, the disease's effect on the United States. Among its findings is that prostate cancer...

10 biggest U.S. gainers for the week.
October 4, 2004... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) Atherogenics 39.59 Lynx Therapeutics 39.04 Ciphergen 28.13 Ortec Int'l 27.86 Immune Resp 25.00 Access Pharma 24.40 Third Wave Tech ...

10 biggest U.S. gainers for the week.
October 4, 2004... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) Valentis -59.43 Northwest BioThera -40.00 Email real estate.com -35.00 Pharsight -19.35 Aeolus -17.13 Deltagen ...

Grants, contracts and awards to biotech companies: July 1-Sept. 30, 2004.
October 4, 2004... Grants, Contracts And Awards To Biotech Companies: July 1-Sept. 30, 2004 Company * Funding (Country; Symbol) Institution Aastrom National Cancer Biosciences Institute Inc....

BioWorld stock report for public biotechnology companies.
October 4, 2004... BioWorld Stock Report For Public Biotechnology Companies %Change Close Close Vol Company Symbol 9/24 10/1 WK...

Fluvirin mistake hurts U.S. plans, Chiron's credibility.(Can Flu Vaccine Hole Be Filled?)
October 11, 2004... It's one thing to report drug production problems and suffer a stock drop--that happens often in the biotech sector--but it's quite another to push the entire U.S. toward a public health crisis. Last week, Chiron Corp. had the distinct dishonor...

10 biggest U.S. gainers for the week.
October 11, 2004... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) StemCells 27.56 Simulations Plus 24.85 Deltagen 20.00 SciClone 19.35 Aastrom Biosci 18.48 Carrington 16.93 Emisphere 16.49...

10 biggest U.S. losers for the week.
October 11, 2004... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) Genelabs -70.40 GenVec -51.88 CytRx -31.40 Access Pharma -29.33 Miravant -26.95 Chiron -20.43 Trimeris -19.44 MannKind ...

Public financing of biotechnology: September 2004.
October 11, 2004... I. COMMENCED TRADING IN SEPTEMBER Company Date Date Shares/ Price Shares (Symbol) (#) Filed Comm. Units (M) Out (M) (@) Company Lead, Other...

Other financings Of public biotechnology companies: September 2004.
October 11, 2004... Other Financings Of Public Biotechnology Companies: September 2004 TOTAL: $971.91M Company Type Of Number Of Amount (Symbol) (#) Financing Shares, Units Raised ...

Venture capital and corporate investments in biotechnology companies: September 2004.
October 11, 2004... I. FINANCING OF PRIVATE BIOTECHNOLOGY COMPANIES: $341.88M Company Location Date Amt. (M) Achillion New Haven, Conn. 9/2/04 $10.30 Pharmaceuticals Inc. Arakis Ltd. Saffron...

Money raised by Biotech in 2004: January-September.
October 11, 2004... Money Raised By Biotech In 2004: January-September Type of Jan. ($M) Feb. ($M) Mar. ($M) Apr. ($M) financing Public offerings 352.1 997.8 586.6 518.2 Private biotechs 444.3 367.0...

BioWorld stock report for public biotechnology companies.
October 11, 2004... BioWorld Stock Report For Public Biotechnology Companies % Change Company Symbol Close Close Vol 10/1 10/8 WK...

Incubate or incorporate? Venture capitalists speak out on methods.
October 18, 2004... SAN FRANCISCO -- Biotechnology is no stranger to protest and picketing, and attendees of the Biotechnology Industry Organization's "Emerging Company Investor Forum" found more of the same at the door of the Palace Hotel here. Sign-carrying...

10 biggest U.S. gainers for the week.
October 18, 2004... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) Eyetech 23.19 Renovis 19.62 Novavax 17.90 Lifecore Bio 17.01 Pharma Prod Devlp 16.48 Cellegy Pharma 14.59 Cerus Corp. ...

10 biggest U.S. losers for the week.
October 18, 2004... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) La Jolla Pharma -67.46 eXegenics -28.79 Deltagen -25.00 Genelabs -21.62 Cell Genesys -21.39 Inhibitex -17.49 Aeolus -16.77...

Correction.(Correction Notice)
October 18, 2004... An entry in the Oct. 11, 2004, issue of BioWorld Financial Watch failed to note that Lazard Freres & Co. was a co-manager of OSI Pharmaceuticals Inc.'s proposed follow-on offering. Editor's note: The correction has been made in BioWorld...

Clinical trials update: September 2004.
October 18, 2004... Clinical Trials Update: September 2004 Company * Product Description (Country; Symbol) AUTOIMMUNE Enzo Biochem Alequel A complex of autologous Inc. (NYSE:ENZ) ...

Non-U.S. clinical trials, regulatory submissions, recommendations and approvals: September 2004.
October 18, 2004... Non-U.S. Clinical Trials, Regulatory Submissions, Recommendations And Approvals: September 2004 Company * Product Description (Country; Symbol) AUTOIMMUNE Amgen Inc. Enbrel Etanercept;...

FDA submissions, approvals and other actions: September 2004.
October 18, 2004... FDA Submissions, Approvals And Other Actions: September 2004 Company * Product Description (Country; Symbol) AUTOIMMUNE Amgen Inc. Enbrel Etanercept; anti-tumor (AMGN) and ...

BioWorld stock report for public biotechnology companies.
October 18, 2004... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close % Change Vol 10/8 10/15 WK YTD (000) Aastrom Biosci ASTM 1.09...

ViroPharma betting on Lilly antibiotic to build pipeline.
October 25, 2004... Take a marketed drug--an antibiotic, say. One that physicians are nervous about over-prescribing, lest resistance arise. One with no patent protection and modest sales, in the range of $40 million per year. One targeted to a condition for which...

10 biggest U.S. gainers for the week.
October 25, 2004... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) StemCells 48.35 ViroPharma 43.00 Repligen 33.33 Ortec Int'l 25.71 GenVec 22.05 Arena 20.61 Simulations Plus 19.44...

10 biggest U.S. losers for the week.
October 25, 2004... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) Advancis -62.83 Imcor -30.77 Dyax -24.85 Genaissance -24.67 Oxis Int'l -20.63 Cytokinetics -18.03 Exact Sciences...

Biotech--big pharma collaborations: new agreements, Aug. 27-Oct. 20, 2004 (#).
October 25, 2004... Biotech--Big Pharma Collaborations: New Agreements, Aug. 27-Oct. 20, 2004 (#) Biotech Co. * Pharma Co. Type/Product Area (Country; (Country) Symbol) Accelrys Inc. Bayer ...

Manufacturing, marketing and distribution agreements between biotech and pharmaceutical companies: Aug. 27-Oct. 20, 2004 (#).
October 25, 2004... Manufacturing, Marketing And Distribution Agreements Between Biotech And Pharmaceutical Companies: Aug. 27 - Oct. 20, 2004 (#) Biotech Co. * Pharma Co. Product (Country; (Country) Symbol) Accelrys...

Biotech--big pharma collaborations: modified and terminated agreements, Aug. 27-Oct. 20, 2004 (#).
October 25, 2004... Biotech--Big Pharma Collaborations: Modified And Terminated Agreements, Aug. 27-Oct. 20, 2004 (#) I. MODIFIED AGREEMENTS Biotech Co. * Pharma Co. Change from original (Country; (Country) ...

BioWorld stock report for public biotechnology companies.
October 25, 2004... BioWorld Stock Report For Public Biotechnology Companies % Change Company Symbol Close Close Vol 10/15 10/22 ...